The University of Cambridge Enterprise Fund generally co-invests alongside the University’s own funds, taking advantage of the infrastructure and expertise already in place.
The Fund will provide the private investor with an opportunity to invest in early stage technology companies as they spin-out of the University, while supplying additional finance to ensure that companies are properly resourced for the initial stages of commercial product development.
The Fund will seek to invest with the tax reliefs of the EIS and SEIS, where applicable.
The minimum subscription to the Fund is £25,000.
Parkwalk Advisors is the Fund Manager and Cambridge Enterprise is the
Investment Advisor for the purposes of sourcing and evaluating investment opportunities for the Fund.
University of Cambridge funds have made over 50 investments, which have jointly raised over £600m of further investment and £30m of grant funding - leveraging the original University investment by over 77x.
Parkwalk manages nine EIS Funds.
The first three fully invested Funds are valued to BVCA guidelines and NAVs are published monthly on the Fund Management home page.
The University of Cambridge Enterprise Fund I started investing in Q3 2012. The Portfolio can be viewed here.
The University of Cambridge: Excellence in Innovation
Cambridge is Europe’s most productive technology cluster, having produced nine
companies valued at more than $1 billion, and two (ARM and Autonomy) valued at more than $10 billion.
Around 1,500 technology companies are based within the Cambridge region, supporting a rich network of expertise across a broad range of technology sectors from software (Autonomy, RedGate), hardware (ARM, NEUL, CSR), technology (CamSemi, Enecsys, Light Blue Optics, Teraview) and biotech (MedImmune, Mission Therapeutics, Kynmab). Active networking groups such as the Cambridge Network, One Nucleus, Cambridge
Wireless and Cambridge Cleantech ensure that young companies can access a wide resource of expertise, finance and services.
At the heart of the cluster sits the University of Cambridge, one of the top 4 Universities in the world. The University has an unbeatable pedigree in innovation – the source of the jet engine, the structure of DNA, monoclonal antibodies and plastic electronics. In recent times, the University has sought to maximise its societal impact by supporting start-up companies created with the purpose of commercialising Cambridge research and the vast majority of technology companies in the cluster are connected to the University in some way: they are either based directly on University research, are founded or staffed by Cambridge graduates, or work collaboratively with University researchers to find solutions to business problems.
These young companies formed around University innovation transform society through new therapies and disruptive technology products. They address the significant issues of today’s society: healthcare, renewable energy, clean water and food. University spin-outs create local and national economic impact and underpin the technological development of industries critical to the UK.
Cambridge Enterprise occupies a unique position at the heart of the University.
Notable start-ups from the University include:
As the University’s technology transfer office it has open access to new technologies as they emerge from the laboratory, and it works with academic entrepreneurs to help them develop their commercialisation strategies from a very early stage.
Through the University’s own seed funds, Cambridge Enterprise manages a portfolio of over 30 investee companies. Starting with a seed investment, Cambridge Enterprise helps the founders to form a commercial strategy around the technology to develop a business capable of attracting the resources necessary for product development and growth. Making between 5 and 8 investments per year, Cambridge Enterprise uses its extensive network of mentors and non-executives to attract the necessary management and follow-on
finance needed as the company develops.